Showing results (591-600 of 1,007) with videos related to

Sort By:
Pageof 101
Transplantation|June 8, 2001
Differential inhibitory effects of intravenous immunoglobulin preparations on HLA-alloantibodies in vitroR Wassmuth, I A Hauser, K Schuler, et al.
Current Biology : CB|May 14, 2021
A novel thylakoid-less isolate fills a billion-year gap in the evolution of CyanobacteriaNasim Rahmatpour, Duncan A Hauser, Jessica M Nelson, et al.
Molecular Vision|August 31, 2012
Low prevalence of myocilin mutations in an African American population with primary open-angle glaucomaWenjing Liu, Yutao Liu, Pratap Challa, et al.
European Journal of Neurology|August 1, 2012
Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's diseaseA H V Schapira, P Barone, R A Hauser, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2013
Novel nicotinic acetylcholine receptor agonists containing carbonyl moiety as a hydrogen bond acceptorAnatoly A Mazurov, David C Kombo, Srinivasa Akireddy, et al.
The Science of the Total Environment|December 4, 2012
Metal and physico-chemical variations at a hydroelectric reservoir analyzed by Multivariate Analyses and Artificial Neural Networks: environmental management and policy/decision-making toolsY L Cavalcante, R A Hauser-Davis, A C F Saraiva, et al.
Brain : a Journal of Neurology|October 24, 2008
Antibody to aquaporin-4 in the long-term course of neuromyelitis opticaS Jarius, F Aboul-Enein, P Waters, et al.
European Journal of Neurology|April 28, 2012
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's diseaseA H V Schapira, P Barone, R A Hauser, et al.
European Journal of Neurology|May 17, 2014
Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's diseaseR A Hauser, A H V Schapira, P Barone, et al.
Frontiers in Neurology|November 7, 2022
Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesiaRajesh Pahwa, Susan Fox, Robert A Hauser, et al.
Pageof 101